Development and validation of an immunosuppressant therapy adherence barrier instrument

Marie A. Chisholm, Charles E. Lance, Gail M. Williamson, Laura L. Mulloy

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Background. To decrease allograft rejection as a result of non-adherence to immunosuppressant therapy (IST), a valid and reliable instrument that measures solid organ transplant patients' adherence barriers is needed. Methods. An immunosuppressant therapy barrier scale (ITBS) was developed to assess transplant patients' perceived barriers to IST adherence and was completed by 222 transplant patients who lived in Georgia, USA. A renal transplant population subset was used to test the ITBS reliability and validity. Scale reliability was estimated using Cronbach's alpha coefficient of internal consistency; scale dimensionality was assessed using principal components analysis. The criterion-related validity of the scale was assessed by relating subscale scores to adherence measures and graft rejection. Nomological validity was assessed by relating barrier subscales to specific patient factors. Results. Two subscales that represented 'controllable' and 'uncontrollable' barriers were found. Cronbach's alpha coefficients demonstrated acceptable reliabilities of 0.93, 0.86 and 0.91 for the 'uncontrollable' and 'controllable' subscales, and for the entire ITBS, respectively. The ITBS subscales correlated negatively with a self-reported measure of IST adherence, IST serum concentrations and IST pharmacy refill adherence rate (P < 0.01). The 'uncontrollable barrier' subscale was positively correlated to kidney graft rejection (P < 0.01), thus demonstrating the ITBS's validity. Males and older patients reported more adherence barriers (P < 0.05). Conclusions. The ITBS is a reliable and valid instrument that can be used to measure patients' perceived barriers to IST adherence.

Original languageEnglish (US)
Pages (from-to)181-188
Number of pages8
JournalNephrology Dialysis Transplantation
Volume20
Issue number1
DOIs
StatePublished - Jan 1 2005

Fingerprint

Immunosuppressive Agents
Therapeutics
Transplants
Graft Rejection
Kidney
Patient Compliance
Principal Component Analysis
Reproducibility of Results
Allografts

Keywords

  • Adherence
  • Compliance
  • Immunosuppressant therapy
  • Kidney transplantation

ASJC Scopus subject areas

  • Nephrology
  • Transplantation

Cite this

Development and validation of an immunosuppressant therapy adherence barrier instrument. / Chisholm, Marie A.; Lance, Charles E.; Williamson, Gail M.; Mulloy, Laura L.

In: Nephrology Dialysis Transplantation, Vol. 20, No. 1, 01.01.2005, p. 181-188.

Research output: Contribution to journalArticle

Chisholm, Marie A. ; Lance, Charles E. ; Williamson, Gail M. ; Mulloy, Laura L. / Development and validation of an immunosuppressant therapy adherence barrier instrument. In: Nephrology Dialysis Transplantation. 2005 ; Vol. 20, No. 1. pp. 181-188.
@article{fbad7145dea04a7e9f394b40a20acc89,
title = "Development and validation of an immunosuppressant therapy adherence barrier instrument",
abstract = "Background. To decrease allograft rejection as a result of non-adherence to immunosuppressant therapy (IST), a valid and reliable instrument that measures solid organ transplant patients' adherence barriers is needed. Methods. An immunosuppressant therapy barrier scale (ITBS) was developed to assess transplant patients' perceived barriers to IST adherence and was completed by 222 transplant patients who lived in Georgia, USA. A renal transplant population subset was used to test the ITBS reliability and validity. Scale reliability was estimated using Cronbach's alpha coefficient of internal consistency; scale dimensionality was assessed using principal components analysis. The criterion-related validity of the scale was assessed by relating subscale scores to adherence measures and graft rejection. Nomological validity was assessed by relating barrier subscales to specific patient factors. Results. Two subscales that represented 'controllable' and 'uncontrollable' barriers were found. Cronbach's alpha coefficients demonstrated acceptable reliabilities of 0.93, 0.86 and 0.91 for the 'uncontrollable' and 'controllable' subscales, and for the entire ITBS, respectively. The ITBS subscales correlated negatively with a self-reported measure of IST adherence, IST serum concentrations and IST pharmacy refill adherence rate (P < 0.01). The 'uncontrollable barrier' subscale was positively correlated to kidney graft rejection (P < 0.01), thus demonstrating the ITBS's validity. Males and older patients reported more adherence barriers (P < 0.05). Conclusions. The ITBS is a reliable and valid instrument that can be used to measure patients' perceived barriers to IST adherence.",
keywords = "Adherence, Compliance, Immunosuppressant therapy, Kidney transplantation",
author = "Chisholm, {Marie A.} and Lance, {Charles E.} and Williamson, {Gail M.} and Mulloy, {Laura L.}",
year = "2005",
month = "1",
day = "1",
doi = "10.1093/ndt/gfh576",
language = "English (US)",
volume = "20",
pages = "181--188",
journal = "Nephrology Dialysis Transplantation",
issn = "0931-0509",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Development and validation of an immunosuppressant therapy adherence barrier instrument

AU - Chisholm, Marie A.

AU - Lance, Charles E.

AU - Williamson, Gail M.

AU - Mulloy, Laura L.

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Background. To decrease allograft rejection as a result of non-adherence to immunosuppressant therapy (IST), a valid and reliable instrument that measures solid organ transplant patients' adherence barriers is needed. Methods. An immunosuppressant therapy barrier scale (ITBS) was developed to assess transplant patients' perceived barriers to IST adherence and was completed by 222 transplant patients who lived in Georgia, USA. A renal transplant population subset was used to test the ITBS reliability and validity. Scale reliability was estimated using Cronbach's alpha coefficient of internal consistency; scale dimensionality was assessed using principal components analysis. The criterion-related validity of the scale was assessed by relating subscale scores to adherence measures and graft rejection. Nomological validity was assessed by relating barrier subscales to specific patient factors. Results. Two subscales that represented 'controllable' and 'uncontrollable' barriers were found. Cronbach's alpha coefficients demonstrated acceptable reliabilities of 0.93, 0.86 and 0.91 for the 'uncontrollable' and 'controllable' subscales, and for the entire ITBS, respectively. The ITBS subscales correlated negatively with a self-reported measure of IST adherence, IST serum concentrations and IST pharmacy refill adherence rate (P < 0.01). The 'uncontrollable barrier' subscale was positively correlated to kidney graft rejection (P < 0.01), thus demonstrating the ITBS's validity. Males and older patients reported more adherence barriers (P < 0.05). Conclusions. The ITBS is a reliable and valid instrument that can be used to measure patients' perceived barriers to IST adherence.

AB - Background. To decrease allograft rejection as a result of non-adherence to immunosuppressant therapy (IST), a valid and reliable instrument that measures solid organ transplant patients' adherence barriers is needed. Methods. An immunosuppressant therapy barrier scale (ITBS) was developed to assess transplant patients' perceived barriers to IST adherence and was completed by 222 transplant patients who lived in Georgia, USA. A renal transplant population subset was used to test the ITBS reliability and validity. Scale reliability was estimated using Cronbach's alpha coefficient of internal consistency; scale dimensionality was assessed using principal components analysis. The criterion-related validity of the scale was assessed by relating subscale scores to adherence measures and graft rejection. Nomological validity was assessed by relating barrier subscales to specific patient factors. Results. Two subscales that represented 'controllable' and 'uncontrollable' barriers were found. Cronbach's alpha coefficients demonstrated acceptable reliabilities of 0.93, 0.86 and 0.91 for the 'uncontrollable' and 'controllable' subscales, and for the entire ITBS, respectively. The ITBS subscales correlated negatively with a self-reported measure of IST adherence, IST serum concentrations and IST pharmacy refill adherence rate (P < 0.01). The 'uncontrollable barrier' subscale was positively correlated to kidney graft rejection (P < 0.01), thus demonstrating the ITBS's validity. Males and older patients reported more adherence barriers (P < 0.05). Conclusions. The ITBS is a reliable and valid instrument that can be used to measure patients' perceived barriers to IST adherence.

KW - Adherence

KW - Compliance

KW - Immunosuppressant therapy

KW - Kidney transplantation

UR - http://www.scopus.com/inward/record.url?scp=13444257825&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13444257825&partnerID=8YFLogxK

U2 - 10.1093/ndt/gfh576

DO - 10.1093/ndt/gfh576

M3 - Article

C2 - 15572384

AN - SCOPUS:13444257825

VL - 20

SP - 181

EP - 188

JO - Nephrology Dialysis Transplantation

JF - Nephrology Dialysis Transplantation

SN - 0931-0509

IS - 1

ER -